Neupath Health Inc. (TSE:NPTH) has released an update.
NeuPath Health Inc. reported a revenue increase for both the fourth quarter and full year of 2023, with a 4% rise to $16.8 million in Q4 and a 6% annual growth, totaling $66.1 million. The company achieved its 20th consecutive quarter of positive adjusted EBITDA at $0.8 million and more than doubled its cash balance to $3.2 million year-over-year. Additionally, NeuPath has expanded its operations by acquiring the London Spine Centre, enhancing its network of chronic pain treatment clinics.
For further insights into TSE:NPTH stock, check out TipRanks’ Stock Analysis page.
